IPDiA offers Advanced Foundry Services to Medical and Hi-Rel companies

IPDiA offers Advanced Foundry Services to Medical and Hi-Rel companies

After obtaining ISO 13485 certification in 2012 for medical devices, IPDiA unveils its ability to offer semiconductor process optimization and transfer applied to medical and Hi-Rel applications. IPDiA thereby plays the role of a high quality and high reliability foundry and joins the restricted circle of ISO qualified medical device fabs. These foundry services are provided as an adjunct to what IPDiA is already recognized for in the electronics industry, i.e. leader in passive components on Silicon and in advanced micro-packaging.

Since its creation in 2009, IPDiA Silicon based 3D-IPD advanced technology shows its added value in fields such as harsh environment, medical, automotive, communication, industrial, and defense/aerospace markets. IPDiA is in fact already well known as holder of the world record in terms of integration of capacitors in silicon, electrical performance and reliability thanks to its advanced technology PICS (Passive Integration Connecting Substrate). High-density trench capacitors, MIM capacitors, resistors, high-Q inductors can be implemented in silicon allowing their integration in various packaging technologies with active devices suitable for very high reliability applications. The medical field is demanding this type of technology, realizing that this is the way to miniaturization for implantable devices. This explains why IPDiA products have already been adopted by 3 of the top 5 leaders in medical electronics.

IPDiA, one-stop-shop from design to production





IPDiA now reveals a new side of its capabilities by providing process optimization and transfer in order to respond to the growing demand of fabless semiconductor companies or small to mid-size fabs that do not have the infrastructure necessary for high quality industrialization of their products.















With four specific projects initiated at the beginning of the year and planned to be industrialized in 2014-2015, IPDiA shows outstanding flexibility and adaptability to fulfill a wide range of customer requirements in medical and Hi-Rel applications.For one of these projects, IPDiA has been chosen as R&D partner to support the innovation developed in the customer’s Research Center. IPDiA R&D experts are conducting product development in situ in order to achieve industrialization in line with the development conditions. IPDiA provides a final miniaturized solution thanks to high performance Integrated Passive Devices complemented by assembly of the full system IPD-actives-MEMS. The advantage is obvious with an ‘all in one’ highly reliable solution and therefore improved time to market.

In the second and third projects, IPDiA expands its scope to components other than passives such as MOS transistors, MEMS, sensors, etc. The R&D team works closely with the customer on the final stages of development to make it compatible with IPDiA facilities.

The last project is a process transfer following product development and first prototypes produced in the customer’s R&D center. On this project, IPDiA supports the final stages of product development, offers a production line specifically dedicated to the customer’s product requirements and ensures the effective process transfer up to the final product industrialization.

Among these 4 projects, 2 are medical orientated products.

To fulfill and anticipate the high level requirements in medical applications, IPDiA rapidly set up a process to obtain ISO 13485 certification and got it right first time in January 2012. This certification represents the requirements for a comprehensive management system for the design and manufacture of medical devices. It shows the ability to foresee new technologies and opportunities linked to these medical devices. This includes:

• focusing on risk management activities and design control activities during product development
• applying specific requirements for inspection and traceability for implantable devices
• controlling the work environment to ensure product safety (non-contamination for instance)












In short, this ISO certificate is essential for engaging trustful and long term partnerships with medical players.

To best meet all the criteria requested in medical applications, IPDiA foundry uses bio-compatible materials such as parylene and platinum commonly used for implantable devices.

Conclusion: IPDiA stands out with its advanced technology and innovations, in-depth knowledge in terms of process optimization, its tradition of excellence with a long record of quality certifications, cutting-edge equipment and industrial facilities. Advantages which make the Company an exceptional and reliable partner for all medical and Hi-Rel applications, on both short runs and high volume productions.

About IPDiA industrial capabilities:
• Quality Certifications: ISO 9001 / 14001 / 18001 / 13485 / TS 16949 and RoHS compliant
• Silicon foundry
• Clean room surfaces in operation : 3300 m2
• Clean room surfaces dedicated to new projects: 500 m2
• Clean room: class 10
• Silicon wafer: 6”, 150 mm FlatSemiStd
• Silicon wafer thickness: > 350 µm
• Minimum lithography dimension: 0.8 µm
• Automatic inspection: 100 %
• Technology: Integrated Passive Components (IPD), MOS transistors, MEMS, sensors
• Line yield: 98 %
• PCM & E-sort measurement & analysis

For further information regarding deep etching, epitaxial capabilities please check website: www.ipdia.com

ISO Catalogue: ISO 13485 : 2003 Medical devices — Quality management systems — Requirements for regulatory purposes
Press Contact
Laëtitia OMNES
+33 231 535 406


For further information on the global market for integrated passive devices, see Paumanok’s new report on Linear and Non-Linear resistors with its special segment on these emerging markets

Resistors: World Markets, Technologies & Opportunities: 2014-2019 ISBN# 1-89-3211-38-X (LNL2014)